Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2023-01-18 00:00:00 ET · period of report 2023-01-16 · accession 0001104659-23-004730 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-18 | 2023-01-16 | PTGX | Gupta Suneel | Chief Development Off | A - Grant | $0.00 | +20.6K | 138.2K | +18% | $0 |
| D | 2023-01-18 | 2023-01-16 | PTGX | Gupta Suneel | Chief Development Off | A - Grant | $0.00 | +123.8K | 123.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-16 | A | A | 20,625 | $0.00 | 138,187 | D | — | — | (F1) Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on January 15, 2024, 2025 and 2026. (F2) Includes 1 share acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2022. |
| 2 | Derivative | Stock Option (right to buy) | 2023-01-16 | A | A | 123,750 | $0.00 | 123,750 | D | $12.17 · — to 2033-01-15 | 123,750 Common Stock | (F3) The stock option vests in 48 equal monthly installments following the date of grant. |